{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:13:36Z","timestamp":1770491616245,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51672176"],"award-info":[{"award-number":["51672176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21901157"],"award-info":[{"award-number":["21901157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SJTU Global Strategic Partnership Fund","award":["2020 SJTU-HUJI"],"award-info":[{"award-number":["2020 SJTU-HUJI"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The lack of a vaccine or any effective treatment for the aggressive novel coronavirus disease (COVID-19) has created a sense of urgency for the discovery of effective drugs. Several repurposing pharmaceutical candidates have been reported or envisaged to inhibit the emerging infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but their binding sites, binding affinities and inhibitory mechanisms are still unavailable. In this study, we use the ligand-protein docking program and molecular dynamic simulation to ab initio investigate the binding mechanism and inhibitory ability of seven clinically approved drugs (Chloroquine, Hydroxychloroquine, Remdesivir, Ritonavir, Beclabuvir, Indinavir and Favipiravir) and a recently designed \u03b1-ketoamide inhibitor (13b) at the molecular level. The results suggest that Chloroquine has the strongest binding affinity with 3CL hydrolase (Mpro) among clinically approved drugs, indicating its effective inhibitory ability for SARS-CoV-2. However, the newly designed inhibitor 13b shows potentially improved inhibition efficiency with larger binding energy compared with Chloroquine. We further calculate the important binding site residues at the active site and demonstrate that the MET 165 and HIE 163 contribute the most for 13b, while the MET 165 and GLN 189 for Chloroquine, based on residual energy decomposition analysis. The proposed work offers a higher research priority for 13b to treat the infection of SARS-CoV-2 and provides theoretical basis for further design of effective drug molecules with stronger inhibition.<\/jats:p>","DOI":"10.1093\/bib\/bbaa209","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T11:20:43Z","timestamp":1597317643000},"page":"1225-1231","source":"Crossref","is-referenced-by-count":32,"title":["Potential inhibitors for the novel coronavirus (SARS-CoV-2)"],"prefix":"10.1093","volume":"22","author":[{"given":"Yanqiang","family":"Han","sequence":"first","affiliation":[{"name":"Shanghai Jiao Tong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilong","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Ren","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Wei","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Science and Technology on Micro\/Nano Fabrication; Key Laboratory for Thin Film and Microfabrication of Ministry of Education, Department of Micro\/Nano Electronics, Shanghai Jiao Tong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4661-4051","authenticated-orcid":false,"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Science and Technology on Micro\/Nano Fabrication, Shanghai Jiao Tong University, Shanghai, 200240, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"2021032314265180300_ref1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"key":"2021032314265180300_ref2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.20.913368","article-title":"Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China","author":"Dong","year":"2020","journal-title":"bioRxiv"},{"key":"2021032314265180300_ref3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.drudis.2016.09.019","article-title":"Design of efficient computational workflows for in silico drug repurposing","volume":"22","author":"Vanhaelen","year":"2017","journal-title":"Drug Discov Today"},{"key":"2021032314265180300_ref4","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.2174\/0929867325666180530100332","article-title":"Computational drug repurposing: current trends","volume":"26","author":"Karaman","year":"2019","journal-title":"Curr Med Chem"},{"key":"2021032314265180300_ref5","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.11829102.v1","article-title":"Potential 2019-nCoV 3C-like protease inhibitors designed using generative deep learning approaches","author":"Zhavoronkov","year":"2020"},{"key":"2021032314265180300_ref6","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202002.0242.v2","article-title":"Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking","author":"Chang","year":"2020"},{"key":"2021032314265180300_ref7","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1758791","article-title":"Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes","author":"Elmezayen","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"2021032314265180300_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"2021032314265180300_ref9","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"2021032314265180300_ref10","doi-asserted-by":"crossref","first-page":"e00221","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"MBio"},{"key":"2021032314265180300_ref11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","author":"Wit","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"2021032314265180300_ref12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"2021032314265180300_ref13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"2021032314265180300_ref14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"2021032314265180300_ref15","doi-asserted-by":"crossref","first-page":"I5371","DOI":"10.1136\/bmj.l5371","article-title":"New treatments for Ebola virus disease","volume":"366","author":"Lucey","year":"2019","journal-title":"BMJ"},{"key":"2021032314265180300_ref16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"2021032314265180300_ref17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","article-title":"Conservation of substrate specificities among coronavirus main proteases","volume":"83","author":"Hegyi","year":"2002","journal-title":"J Gen Virol"},{"key":"2021032314265180300_ref18","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"\u03b1-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"2021032314265180300_ref19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2021032314265180300_ref20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from COVID-19 virus and discovery of its inhibitors","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"2021032314265180300_ref21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The protein data bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2021032314265180300_ref22","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1021\/ja00172a038","article-title":"Semianalytical treatment of solvation for molecular mechanics and dynamics","volume":"112","author":"Still","year":"1990","journal-title":"J Am Chem Soc"},{"key":"2021032314265180300_ref23","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"2021032314265180300_ref24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"2021032314265180300_ref25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcc.10378","article-title":"Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures","volume":"25","author":"Feig","year":"2004","journal-title":"J Comput Chem"},{"key":"2021032314265180300_ref26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/acs.jcim.5b00173","article-title":"A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 protease based on thermodynamic integration and MM-PBSA methods","volume":"55","author":"Chen","year":"2015","journal-title":"J Chem Inf Model"},{"key":"2021032314265180300_ref27","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","author":"Chloroquine","year":"2012"},{"key":"2021032314265180300_ref28","article-title":"The crystal structure of 2019-NCoV main protease in complex with an inhibitor N3","volume-title":"RCSB Protein Data Bank","author":"Liu","year":"2020"},{"key":"2021032314265180300_ref29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jtbi.2008.07.030","article-title":"Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors","volume":"254","author":"Nukoolkarn","year":"2008","journal-title":"J Theor Biol"},{"key":"2021032314265180300_ref30","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/pro.192","article-title":"Blind docking of pharmaceutically relevant compounds using RosettaLigand","volume":"18","author":"Davis","year":"2009","journal-title":"Protein Sci"},{"key":"2021032314265180300_ref31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jmb.2008.11.010","article-title":"RosettaLigand docking with full ligand and receptor flexibility","volume":"385","author":"Davis","year":"2009","journal-title":"J Mol Biol"},{"key":"2021032314265180300_ref32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.str.2011.05.012","article-title":"Status of GPCR modeling and docking as reflected by community-wide GPCR dock 2010 assessment","volume":"19","author":"Kufareva","year":"2011","journal-title":"Structure"},{"key":"2021032314265180300_ref33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00894-019-4188-z","article-title":"Computational characterization of the glutamate receptor antagonist perampanel and its close analogs: density functional exploration of conformational space and molecular docking study","volume":"25","author":"Guseynov","year":"2019","journal-title":"J Mol Model"},{"key":"2021032314265180300_ref34","first-page":"810","volume-title":"AMBER 2016","author":"Case","year":"2016"},{"key":"2021032314265180300_ref35","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J Chem Theory Comput"},{"key":"2021032314265180300_ref36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"key":"2021032314265180300_ref37","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/jcc.21900","article-title":"Fast and accurate computation schemes for evaluating vibrational entropy of proteins","volume":"32","author":"Xu","year":"2011","journal-title":"J Comput Chem"},{"key":"2021032314265180300_ref38","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1021\/ci3001919","article-title":"The normal-mode entropy in the MM\/GBSA method: effect of system truncation, buffer region, and dielectric constant","volume":"52","author":"Genheden","year":"2012","journal-title":"J Chem Inf Model"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/1225\/36654491\/bbaa209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/2\/1225\/36654491\/bbaa209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T14:30:36Z","timestamp":1616509836000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/22\/2\/1225\/5907953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,9,18]]},"published-print":{"date-parts":[[2021,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa209","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,9,18]]}}}